SEC Form 4 · accession 0001933414-26-000094
Mineralys Therapeutics, Inc. · MLYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Malcom Rodman
Officer — Chief Medical Officer
Period of report
Jun 15, 2026
Accepted (ET)
Jun 17, 2026 · 9:18 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001933414
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2026 | M | 3,542 | $10.20 | A | 66,985 | D | |
| Common StockF2 | Jun 15, 2026 | S | 9,890 | $23.8106 | D | 57,095 | D | |
| Common Stock | Jun 17, 2026 | M | 4,167 | $14.25 | A | 61,262 | D | |
| Common Stock | Jun 17, 2026 | M | 417 | $15.44 | A | 61,679 | D | |
| Common Stock | Jun 17, 2026 | S | 4,584 | $25.00 | D | 57,095 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF3 | $10.20 | Jun 15, 2026 | M | 3,542 | D | — | Feb 13, 2035 | Common Stock | 3,542 | 113,334 | D |
| Stock OptionF4 | $14.25 | Jun 17, 2026 | M | 4,167 | D | — | Feb 13, 2034 | Common Stock | 4,167 | 83,334 | D |
| Stock OptionF4 | $15.44 | Jun 17, 2026 | M | 417 | D | — | Mar 17, 2033 | Common Stock | 417 | 3,750 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.
- F2The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $23.41 to $23.98. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
- F3The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant.
- F4The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.